ATE461277T1 - Seb-modifikation und diese enthaltendes vorbeugendes mittel/heilmittel gegen krankheiten mit einer immunanomalität - Google Patents

Seb-modifikation und diese enthaltendes vorbeugendes mittel/heilmittel gegen krankheiten mit einer immunanomalität

Info

Publication number
ATE461277T1
ATE461277T1 AT04723360T AT04723360T ATE461277T1 AT E461277 T1 ATE461277 T1 AT E461277T1 AT 04723360 T AT04723360 T AT 04723360T AT 04723360 T AT04723360 T AT 04723360T AT E461277 T1 ATE461277 T1 AT E461277T1
Authority
AT
Austria
Prior art keywords
seb
anomality
immune
modification
preventive agent
Prior art date
Application number
AT04723360T
Other languages
English (en)
Inventor
Toshihiro Nakashima
Takumi Sasaki
Kazuhiko Kimachi
Shigeki Kuwata
Tsukasa Nishihara
Atsuko Sakata
Masao Ohkuchi
Tomoyuki Koshi
Toshiyuki Edano
Original Assignee
Chemo Sero Therapeut Res Inst
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeut Res Inst, Kowa Co filed Critical Chemo Sero Therapeut Res Inst
Application granted granted Critical
Publication of ATE461277T1 publication Critical patent/ATE461277T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1271—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT04723360T 2003-03-28 2004-03-25 Seb-modifikation und diese enthaltendes vorbeugendes mittel/heilmittel gegen krankheiten mit einer immunanomalität ATE461277T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003091819 2003-03-28
PCT/JP2004/004184 WO2004087915A1 (ja) 2003-03-28 2004-03-25 Ｓｅｂ改変体およびそれを含有する免疫異常性疾患の予防・治療用剤

Publications (1)

Publication Number Publication Date
ATE461277T1 true ATE461277T1 (de) 2010-04-15

Family

ID=33127298

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04723360T ATE461277T1 (de) 2003-03-28 2004-03-25 Seb-modifikation und diese enthaltendes vorbeugendes mittel/heilmittel gegen krankheiten mit einer immunanomalität

Country Status (6)

Country Link
US (1) US8226958B2 (de)
EP (1) EP1609860B1 (de)
JP (1) JP4516914B2 (de)
AT (1) ATE461277T1 (de)
DE (1) DE602004026039D1 (de)
WO (1) WO2004087915A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0401876D0 (sv) 2004-07-16 2004-07-16 Forskarpatent I Syd Ab Prevention of allergy in children
WO2014025199A2 (ko) * 2012-08-09 2014-02-13 주식회사 한독 스테필로코칼 엔테로톡신 유래의 초항원 변이체 및 이에 표적 특이적 폴리펩타이드가 연결된 융합단백질 및 그 용도
CN112028994B (zh) * 2020-07-30 2022-04-05 北京弘进久安生物科技有限公司 抗金黄色葡萄球菌肠毒素b的抗体、检测试纸及试剂盒

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5728388A (en) * 1989-10-03 1998-03-17 Terman; David S. Method of cancer treatment
JPH08500328A (ja) * 1992-01-28 1996-01-16 ナショナル ジューイッシュ センター フォア イミュノロジィ アンド レスパラトリィ メディスン 突然変異したスーパー抗原の保護作用
JPH09110704A (ja) 1995-10-19 1997-04-28 Chemo Sero Therapeut Res Inst 免疫異常性疾患予防治療用経口投与剤
AU746372B2 (en) 1998-02-15 2002-04-18 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Novel preventives/remedies for immunopathy
SE0102327D0 (sv) * 2001-06-28 2001-06-28 Active Biotech Ab A novel engineered superantigen for human therapy

Also Published As

Publication number Publication date
EP1609860A1 (de) 2005-12-28
WO2004087915A1 (ja) 2004-10-14
DE602004026039D1 (de) 2010-04-29
US8226958B2 (en) 2012-07-24
JP4516914B2 (ja) 2010-08-04
US20070166331A1 (en) 2007-07-19
EP1609860A4 (de) 2006-06-14
JPWO2004087915A1 (ja) 2006-07-06
EP1609860B1 (de) 2010-03-17

Similar Documents

Publication Publication Date Title
NZ612315A (en) Compositions for immunising against staphylococcus aureus
BRPI0515516A (pt) composição imunogênica, vacina, métodos de fabricar uma vacina e de prevenir ou tratar infecção estafilocócica, uso da composição imunogênica, método de preparar um globulina imune para uso na prevenção ou tratamento de infecção estafilocócica, composição farmacêutica, e, uso da composição farmacêutica
EP1041149B8 (de) Impfstoff und Antitoxine zur Behandlung und Vorbeugung von C. Difficile Krankheiten
ATE451119T1 (de) Untereinheit-impfstoff gegen das respiratorische synzytialvirus
CY1112851T1 (el) Μεθοδος προληψης ή θεραπειας μολυνσης μ. τuβεrculosis
CY1110783T1 (el) Μονοκλωνικα αντισωματα κατα αυξητικου παραγοντα ηπατοκυτταρων
WO2006042149A3 (en) Determining and reducing immunoresistance to botulinum toxin therapy using botulinum toxin a peptides
IL211037A (en) Antigen @ reactant @ with @ serum @ hyper
ATE542829T1 (de) Impfstoff
DK1534335T3 (da) FcgammaRIIB-specifikke antistoffer og fremgangsmåder til anvendelse deraf
DE602004008329D1 (de) Botulinustoxin-therapie für hauterkrankungen
WO2009083225A3 (en) Antibody-containing formulation for the use for treating cardiovascular diseases associated with atherosclerosis
DE60328747D1 (de) Reinigung von polyreaktiven Autoantikörpern und deren Verwendungen
WO2018027124A8 (en) ANTI-O2 ANTIBODIES AND USES THEREOF
ATE458496T1 (de) Hiv-vakzine und anwendungsverfahren
WO2009005040A1 (ja) 緑膿菌の外膜タンパク質pa4710
ATE461277T1 (de) Seb-modifikation und diese enthaltendes vorbeugendes mittel/heilmittel gegen krankheiten mit einer immunanomalität
ATE477274T1 (de) Gegen clostridium difficile gerichtete antikörper
WO2007140244A3 (en) Vaccination of young animals against lawsonia intracellularis infections
WO2008057158A3 (en) Novel neutralizing immunogen (nimiv) of rhinovirus and its use for vaccine applications
WO2002092131A3 (en) Immunogenic conjugates of low molecular weight hyaluronic acid with polypeptide toxins
WO2003046007A3 (en) Treatment of micro-organism infection
BR0307627A (pt) Métodos e composições para o tratamento de doenças do olho
BR0112497A (pt) Antìgenos de streptococcus pyogenes
WO2010142030A8 (en) Different serotypes of vesicular stomatitis virus as expression vectors for immunization regimens

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1609860

Country of ref document: EP